EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Douglas Connect (2 hours ago)
Next eChemInfo Oxford 2018 https://t.co/UdCPTh4NtS
Douglas Connect (2 days ago)
RT @madAniceP: #echeminfo EURO 2018 #workshop in Milan is over. What a great week full of exciting #compchem talks and hands-on #Tutorials.…
Douglas Connect (3 days ago)
RT @ivanoeberini: Are you ready for #echeminfo today? @DouglasConn https://t.co/lUZe4Wd25q
Douglas Connect (6 days ago)
RT @madAniceP: #echeminfo workshop @DouglasConn day2 just started with a great speaker Paul Hawkins from @OpenEyeSoftware and his illuminat…
Douglas Connect (6 days ago)
RT @ivanoeberini: Ready for #echeminfo EURO 2018 @DouglasConn: novel molecular modelling strategies for drug discovery at @LaStatale https:…

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com